"It has long been my vision of developing quality natural healthcare products and sharing these with people around the world."

SFI Chairman and Founder
Mr Eng Liang Tan

SFI Board of Directors

Eng Liang Tan

SFI Executive Chairman / President Commissioner of SOHO Global Health

more

Under Eng Liang Tan’s guidance, Soho Global Heath has grown from being a family company into one of the largest pharmaceutical companies in Southeast Asia.

Eng Liang Tan graduated from University of Bochum, Germany with a major in Nuclear Physics, and from the Business Management School in University of Bradford, United Kingdom. His long career includes experience with ICI Pharmaceutical Division (now Astra Zeneca), Warner Lambert Inc. (now Pfizer Inc.) and Beecham (now GSK).

Nigel Pollard

Chief Executive Officer

more

Nigel established Flordis Pty Ltd in 2001 to meet consumer demand for natural healthcare products backed by clinical research. Following the success and growth of Flordis, Nigel went on to establish Soho Flordis International with Mr Eng Liang Tan and share its growing portfolio of natural healthcare products with the world.

Nigel holds an honours degree in Biochemistry and post graduate Marketing and International Director qualifications. He established his career in sales, international marketing and business development in the pharmaceutical industry in Europe and Australia.

David Ebsworth

Board Member

more

David recently retired as CEO of Galenica AG and its subsidiary Vifor Pharma Ltd, and joined SFI’s Board following its acquisition of Potter’s Herbals. Prior to this, David has served as CEO of Oxford Glycosciences PLC and as Head of Pharma Business at Bayer AG. In addition, David has served as Chairman and Board member for a number of companies based in the US, Germany, Austria, Italy, Netherlands, UK and Japan. David is also currently Chairman of Verona Pharma PLC, a drug development company listed on the London AIM market.

David holds a Bachelor of Science in Chemistry and German as well as a PhD in comparative Industrial Relations from the University of Surrey, where he is also a visiting Professor at the University of Surrey’s Business School.

Erica Mann

Board Member

more

Erica Mann is a former Board Member of Bayer AG and the former President of the Consumer Health Division. Erica was the first women to be appointed to Bayer’s board in the company’s 150 year history. As President of Consumer Health at Bayer AG, Erica directed every aspect of one of the world’s leading global OTC companies.  She led the expansion of the business in key emerging markets; oversaw significant acquisitions such as Steigerwald (Germany), Merck Consumer Care (USA), and Dihon Pharmaceutical Group (China).

Erica was the chair of the World Self Medication Industry Association, the global association for the over-the-counter drug industry, and was the first woman to serve in this capacity.  She has held executive positions in several industry organisations, including the South African Pharmaceutical Manufacturers’ Association (PMA) and Medicines Australia, as well as the International Association of Infant Food Manufacturers. Erica has over 30 years of experience in the healthcare industry and is a true global citizen who has lived, worked and breathed the culture of 4 continents. She holds an undergraduate degree in Analytical Chemistry and a Diploma in Marketing Management. 

Erica was listed in Fortune’s ‘Most Powerful Women International’ both in 2016 (ranked # 40) and 2017 (ranked # 36). Erica was also selected to participate in Nelson Mandela's successful Trade Mission to the UK in 1996.Erica was born in Vereeniging, South Africa, is an Australian citizen and has two adult sons.

 

SFI Senior Executive Team

Nigel Pollard

Chief Executive Officer

more

Nigel established Flordis Pty Ltd in 2001 to meet consumer demand for natural healthcare products backed by clinical research. Following the success and growth of Flordis, Nigel went on to establish Soho Flordis International with Mr Eng Liang Tan and share its growing portfolio of natural healthcare products with the world.

Nigel holds an honours degree in Biochemistry and post graduate Marketing and International Director qualifications. He established his career in sales, international marketing and business development in the pharmaceutical industry in Europe and Australia.

Robert Hendriks

Chief Operating Officer / Acting General Manager EMEA

more

Robert has successfully managed local and global sales and marketing functions and led a number of international organisations for Organon and Genzyme. In his career that spans over 20 years he developed experience in the pharmaceutical, biotech, medical devices and natural medicines industries.

Robert graduated as medical doctor from the University of Amsterdam, Netherlands and holds an MBA from the Erasmus University, Netherlands. He is also a graduate of the Australian Institute of Company Directors

 

 

 

 

Arvinder Grover

Group Head Human Resources

more

With over 15 years’ experience both locally and internationally, Arvinder oversees SFI’s People Management Strategy; focused on developing the talent and leadership needed to foster innovation and drive sustainable growth. A key area of focus for Arvinder is harnessing SFI’s capabilities and knowledge globally, while ensuring strong local teams to successfully deliver the business strategy and facilitating cultural change.

Arvinder holds a degree in HR Management and a PG Diploma in Business Management.

Brent Bailey

General Manager Americas

more

Brent has an extensive strategic marketing and general management background, including serving as CEO of a NASDAQ listed company.  He has 10-years’ experience in the nutritional supplements industry leading Cyanotech (BioAstin and Spirulina Pacifica) and Pharmavite (Nature Made).  His background also includes general management roles at Dial Corporation and senior marketing roles in the food industry (Del Monte Foods, Van De Kamp’s Frozen Foods and Frito-Lay); personal care; and a healthcare start-up. 

He holds an MBA from UCLA and a BA from Claremont McKenna College.
 

John Cheok

General Manager Asia

more

John has extensive experience in general management, strategic marketing, sales management, business intelligence and consulting experience in the healthcare sector. He has over 20 years’ experience working in leading Global Pharma companies of Roche and Knoll AG and ran his own consultancy for a time. For the last 5 years he has worked at SFI and most recently as the Country Manager of Australia and New Zealand.

He holds a Bachelor of Economics degree from Macquarie University

Gian Luca Ligas

Group Head of Medical & Marketing

more

Gian Luca has an extensive marketing, commercial and scientific experience both locally and globally, managing Brands across different therapeutical areas in the Healthcare sector.
Prior to joining SFI in 2014, Gian Luca was working for Abbott where he held different Brand, Marketing and Commercial effectiveness management positions.

Gian Luca has graduated from the University of Turin and holds a Master’s Degree in Pharmaceutical Chemistry. Additionally he holds an MBA and several certificates in Marketing & Management from different International Business Schools (e.g. IESE in Barcelona, MCE in Bruxelles, Bocconi in Milan).

Pier-Francesco Campanini

Group Head Scientific Affairs

more

Francesco’s career includes operations, corporate and international roles in Research & Development, Quality Systems, Quality Assurance, Quality Control and Regulatory Compliance in a number of companies in Italy and Switzerland.

Francesco has a doctorate in Pharmaceutical Technology, with specialisation in Pharmacokinetic and Pharmacodynamics.

Eric Dripps

Global Head of Operations

more

Eric joined SFI-USA in Feb of 2016 as Vice President of Operations where he lead the design, construction and startup of our 75,000 square foot cGMP manufacturing facility in Reno, Nevada. Eric has enjoyed a 25 year career in the nutritional supplements industry where he has lead Operations for US based organizations, operating globally, most notably Metagenics. Over the span of his career, Eric has developed balanced expertise in all facets of the industry, with particular emphasis in Operations. Eric has also lead merger and acquisition activities of brands and legal entities, and has commissioned three green field GMP manufacturing facilities.

Eric is a passionate advocate for delivering best in class products and services that help people to achieve their full health potential, around the globe.

SFI Research

Anthony Noble

General Manager / Executive Director

more

Anthony has more than 10 years of management experience in the biotechnology and healthcare industry including as Principal Scientist for the Australian Cord Blood Service and as a Lead Inspector at the Human Tissue Authority (UK).

Anthony has held various roles in SFI Group since 2010, including Group Head of North Asia and Business to Business and Director of Special Projects. Anthony moved to SFI Research Pty Ltd, at the inception of the dedicated research company in 2015.

Anthony holds a PhD in Cell Biology, an MBA from the Australian Graduate School of Management and is a graduate of the Australian Institute of Company Directors.